FIELD: medicine.
SUBSTANCE: method involves simulating retinal pathology and preventing it by administering recombinant erythropoietin as a preconditioning agent into a laboratory animal. Erythropoietin is administered daily once on the first experimental day intragastrically in a dose of 50 IU/kg 30 minutes before simulating the pathology. The method promotes the pronounced correction of ischemia of the retina ensured by a mechanism of opening of ATP-dependent K+-canals followed by inducing mechanisms of metabolic adaptation in implementing the preconditioning effect.
EFFECT: preventing the ischemic conditions of the retina.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF ISCHEMIA OF RETINA EXPERIMENTALLY | 2013 |
|
RU2539630C1 |
| METHOD FOR RETINAL ISCHEMIA-REPERFUSION PREVENTION BY MINOXIDIL IN EXPERIMENT | 2016 |
|
RU2643671C1 |
| METHOD FOR CORRECTING MICROCIRCULATORY DISORDERS OF THE RETINA WITH ASIALATED ERYTHROPOIETIN | 2021 |
|
RU2762892C1 |
| METHOD FOR CORRECTION OF MICROCIRCULATORY DISORDERS OF THE RETINA WITH LOW-SIALATED ERYTHROPOIETIN | 2021 |
|
RU2750966C1 |
| METHOD FOR PREVENTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2017 |
|
RU2643579C1 |
| METHOD FOR CORRECTING NEURONAL DAMAGE TO THE RETINA WITH DIMETHYLAMINOETHANOL DERIVATIVES IN THE EXPERIMENT | 2022 |
|
RU2782497C1 |
| METHOD FOR PREVENTING MICROCIRCULATION DISORDERS IN KIDNEYS WITH ASIALISED ERYTHROPOIETIN IN EXPERIMENT | 2018 |
|
RU2696864C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION OF PHARMACOLOGICAL PRE-CONDITIONING BY NICORANDIL IN SIMULATED ADMA-LIKE GESTOSIS EXPERIMENTALLY | 2014 |
|
RU2543359C1 |
| METHOD FOR CORRECTING ISCHEMIC NEUROPATHY OF THE OPTIC NERVE WITH A DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN AN EXPERIMENT | 2017 |
|
RU2663643C1 |
| METHOD FOR CORRECTING MICROCIRCULATION DISORDERS IN KIDNEY WITH INFLIXIMAB IN ISCHEMIA-REPERFUSION INJURY | 2021 |
|
RU2753247C1 |
